L. van Dussen PhD publications

2020

• van der Veen Sanne J., Vlietstra Wytze J., van Dussen Laura, van Kuilenburg André B. P., Dijkgraaf Marcel G. W., Lenders Malte, Brand Eva, Wanner Christoph, Hughes Derralynn, Elliott Perry M., Hollak Carla E. M., Langeveld Mirjam Predicting the development of anti-drug antibodies against recombinant alpha-galactosidase a in male patients with classical fabry disease International journal of molecular sciences 2020;21 (16):1-14 [PubMed]

2018

• Regenboog Martine, van Dussen Laura, Verheij Joanne, Weinreb Neal J., Santosa David, vom Dahl Stephan, Häussinger Dieter, Müller Meike N., Canbay Ali, Rigoldi Miriam, Piperno Alberto, Dinur Tama, Zimran Ari, Mistry Pramod K., Salah Karima Yousfi, Belmatoug Nadia, Kuter David J., Hollak Carla E. M. Hepatocellular carcinoma in Gaucher disease: an international case series Journal of inherited metabolic disease 2018;41 (5):819-827 [PubMed]
• Zimran Ari, Dinur Tama, Revel-Vilk Shoshana, Akkerman Eric M., van Dussen Laura, Hollak Carla E. M., Maayan Hannah, Altarescu Gheona, Chertkoff Raul, Maas Mario Improvement in bone marrow infiltration in patients with type I Gaucher disease treated with taliglucerase alfa Journal of inherited metabolic disease 2018;41 (6):1259-1265 [PubMed]

2016

• de Boer Geertje M., van Dussen Laura, van den Toorn Leon M., den Bakker Michael A., Hoek Rogier A. S., Hesselink Dennis A., Hollak Carla E. M., van Hal Peter Th W. Lung Transplantation in Gaucher Disease: A Learning Lesson in Trying to Avoid Both Scylla and Charybdis Chest 2016;149 (1):e1-e5 [PubMed]

2015

• Limonard Eelkje J., Veldhuis-Vlug Annegreet G., van Dussen Laura, Runge Jurgen H., Tanck Michael W., Endert Erik, Heijboer Annemieke C., Fliers Eric, Hollak Carla E., Akkerman Erik M., Bisschop Peter H. Short-Term Effect of Estrogen on Human Bone Marrow Fat Journal of bone and mineral research 2015;30 (11):2058-2066 [PubMed]

2014

• van Dussen Laura, Biegstraaten Marieke, Hollak Carla E. M., Dijkgraaf Marcel G. W. Cost-effectiveness of enzyme replacement therapy for type 1 Gaucher disease Orphanet journal of rare diseases 2014;9 (1):51 [PubMed]
• van Dussen L., Akkerman E. M., Hollak C. E. M., Nederveen A. J., Maas M. Evaluation of an imaging biomarker, Dixon quantitative chemical shift imaging, in Gaucher disease: lessons learned Journal of inherited metabolic disease 2014;37 (6):1003-1011 [PubMed]
• van Dussen L., Lips P., van Essen H. W., Hollak C. E. M., Bravenboer N. Heterogeneous pattern of bone disease in adult type 1 Gaucher disease: clinical and pathological correlates Blood cells, molecules & diseases 2014;53 (3):118-123 [PubMed]
• van Dussen Laura, Biegstraaten Marieke, Dijkgraaf Marcel Gw, Hollak Carla Em Modelling Gaucher disease progression: long-term enzyme replacement therapy reduces the incidence of splenectomy and bone complications Orphanet journal of rare diseases 2014;9 (1):112 [PubMed]
• van Dussen Laura Twenty years of treatment for Gaucher disease: emerging challengess.l: 2014. 349p. ISBN 9789461086013. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Hollak C. E. M., Aerts J. M. F. G.; Co-supervisor: Maas M.)
• van Dussen L., Hendriks E. J., Groener J. E. M., Boot R. G., Hollak C. E. M., Aerts J. M. F. G. Value of plasma chitotriosidase to assess non-neuronopathic Gaucher disease severity and progression in the era of enzyme replacement therapy Journal of inherited metabolic disease 2014;37 (6):991-1001 [PubMed]

2013

• Bohte Anneloes E., van Dussen Laura, Akkerman Erik M., Nederveen Aart J., Sinkus Ralph, Jansen Peter L. M., Stoker Jaap, Hollak Carla E. M. Liver fibrosis in type I Gaucher disease: magnetic resonance imaging, transient elastography and parameters of iron storage PLoS ONE 2013;8 (3):e57507 [PubMed]
• Arends Maarten, van Dussen Laura, Biegstraaten Marieke, Hollak Carla E. M. Malignancies and monoclonal gammopathy in Gaucher disease; a systematic review of the literature British journal of haematology 2013;161 (6):832-842 [PubMed]
• van Dussen L., Zimran A., Akkerman E. M., Aerts J. M. F. G., Petakov M., Elstein D., Rosenbaum H., Aviezer D., Brill-Almon E., Chertkoff R., Maas M., Hollak C. E. M. Taliglucerase alfa leads to favorable bone marrow responses in patients with type I Gaucher disease Blood cells, molecules & diseases 2013;50 (3):206-211 [PubMed]

2012

• Aerts Johannes M. F. G., Ferraz Maria Joao, Boot Rolf G., van Breemen Marielle J., Dekker Nick, Kramer Gertjan, Hollak Carla E. M., Maas Mario, Linthorst Gabor E., Smid Bouwien, Rombach Saskia M., van Dussen Laura, Poorthuis Ben, Groener Johanna E. M. Biomarkers for Lysosomal Storage Disordersin: Sankar Surendran, editors. Neurochemistry of Metabolic Diseases: Lysosomal Storage Diseases, Phenylketonuria and Canavan Disease. Hauppage, New York: Nova Science Publishers; 2012. p. 169-203, ISBN 9781612096711
• Hollak Carla E. M., Belmatoug Nadia, Cole J. Alexander, vom Dahl Stephan, Deegan Patrick B., Goldblatt Jack, Rosenbloom Barry, van Dussen Laura, Tylki-Szymańska Anna, Weinreb Neal J., Zimran Ari, Cappellini Maria Domenica Characteristics of type I Gaucher disease associated with persistent thrombocytopenia after treatment with imiglucerase for 4-5 years British journal of haematology 2012;158 (4):528-538 [PubMed]
• van Dussen Laura, Cox Timothy M., Hendriks Erik J., Morris Elizabeth, Akkerman Erik M., Maas Mario, Groener Johanna E. M., Aerts Johannes M. F. G., Deegan Patrick B., Hollak Carla E. M. Effects of switching from a reduced dose imiglucerase to velaglucerase in type 1 Gaucher disease: clinical and biochemical outcomes Haematologica 2012;97 (12):1850-1854 [PubMed]

2011

• Dekker Nick, van Dussen Laura, Hollak Carla E. M., Overkleeft Herman, Scheij Saskia, Ghauharali Karen, van Breemen Mariëlle J., Ferraz Maria J., Groener Johanna E. M., Maas Mario, Wijburg Frits A., Speijer Dave, Tylki-Szymanska Anna, Mistry Pramod K., Boot Rolf G., Aerts Johannes M. Elevated plasma glucosylsphingosine in Gaucher disease: relation to phenotype, storage cell markers, and therapeutic response Blood 2011;118 (16):e118-e127 [PubMed]
• van Dussen L., Lips P., Everts V. E., Bravenboer N., Jansen I. D. C., Groener J. E. M., Maas M., Blokland J. A. K., Aerts J. M. F. G., Hollak C. E. M. Markers of bone turnover in Gaucher disease: modeling the evolution of bone disease Journal of clinical endocrinology and metabolism 2011;96 (7):2194-2205 [PubMed]

2010

• Hollak Carla E. M., vom Dahl Stephan, Aerts Johannes M. F. G., Belmatoug Nadia, Bembi Bruno, Cohen Yossi, Collin-Histed Tanya, Deegan Patrick, van Dussen Laura, Giraldo Pilar, Mengel Eugen, Michelakakis Helen, Manuel Jeremy, Hrebicek Martin, Parini Rosella, Reinke Jörg, Di Rocco Maja, Pocovi Miguel, Sa Miranda Maria Clara, Tylki-Szymanska Anna, Zimran Ari, Cox Timothy M. Force Majeure: Therapeutic measures in response to restricted supply of imiglucerase (Cerezyme) for patients with Gaucher disease Blood cells, molecules & diseases 2010;44 (1):41-47 [PubMed]
• Boomsma Jooske M. F., van Dussen Laura, Wiersma Maaike G., Groener Johanna E. M., Aerts Johannes M. F. G., Maas Mario, Hollak Carla E. M. Spontaneous regression of disease manifestations can occur in type 1 Gaucher disease; results of a retrospective cohort study Blood cells, molecules & diseases 2010;44 (3):181-187 [PubMed]

2009

• Hollak Carla E. M., de Fost Maaike, van Dussen Laura, vom Dahl Stephan, Aerts Johannes M. F. G. Enzyme therapy for the treatment of type 1 Gaucher disease: clinical outcomes and dose - response relationships Expert opinion on pharmacotherapy 2009;10 (16):2641-2652 [PubMed]
• Boot Rolf G., van Breemen Mariëlle J., Wegdam Wouter, Sprenger Richard R., de Jong Shreyas, Speijer Dave, Hollak Carla E. M., van Dussen Laura, Hoefsloot Huub C. J., Smilde Age K., de Koster Chris G., Vissers Johannes P. C., Aerts Johannes M. F. G. Gaucher disease: a model disorder for biomarker discovery Expert review of proteomics 2009;6 (4):411-419 [PubMed]